Cancer Reversion Therapy: Prospects, Progress and Future Directions

Emmanuel O. Oisakede; David B. Olawade; Oluwakemi Jumoke Bello; Claret Chinenyenwa Analikwu; Eghosasere Egbon; Oluwaseun Fapohunda; Stergios Boussios

doi:https://www.mdpi.com/1467-3045/47/12/1049

Cancer Reversion Therapy: Prospects, Progress and Future Directions

Emmanuel O. Oisakede
, David B. Olawade
, Oluwakemi Jumoke Bello
, Claret Chinenyenwa Analikwu
, Eghosasere Egbon
, Oluwaseun Fapohunda
, Stergios Boussios

Leeds Teaching Hospitals NHS Trust
York St John University
The Clinical Research Centre
University Hospital Southampton NHS Foundation Trust
Department of Tissue Engineering and Regenerative Medicine
University of Arizona
Department of Research and Innovation
Medway NHS Foundation Trust
Swedish School of Sport and Health Sciences
University of Ioannina
Department of Medical Oncology
Ioannina University Hospital
Faculty of Life Sciences & Medicine
School of Cancer & Pharmaceutical Sciences
King’s College London
AELIA Organization

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	1049
Journal	Current Issues in Molecular Biology
Volume	47
Issue number	12
DOIs	https://doi.org/https://www.mdpi.com/1467-3045/47/12/1049
Publication status	Published - 1 Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Differentiation therapy
Epigenetic regulation
Tumor Microenvironment
Cellular Reprogramming
Cancer Reversion

Access to Document

https://www.mdpi.com/1467-3045/47/12/1049Licence: CC BY

Cite this

@article{c0388e5ef2e54d1d9323b4517ed7b16d,

title = "Cancer Reversion Therapy: Prospects, Progress and Future Directions",

keywords = "Differentiation therapy, Epigenetic regulation, Tumor Microenvironment, Cellular Reprogramming, Cancer Reversion",

author = "Oisakede, \{Emmanuel O.\} and Olawade, \{David B.\} and Bello, \{Oluwakemi Jumoke\} and Analikwu, \{Claret Chinenyenwa\} and Eghosasere Egbon and Oluwaseun Fapohunda and Stergios Boussios",

year = "2025",

month = dec,

day = "1",

doi = "https://www.mdpi.com/1467-3045/47/12/1049",

language = "English",

volume = "47",

pages = "1049",

journal = "Current Issues in Molecular Biology",

issn = "1467-3037",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "12",

}

TY - JOUR

T1 - Cancer Reversion Therapy: Prospects, Progress and Future Directions

AU - Oisakede, Emmanuel O.

AU - Olawade, David B.

AU - Bello, Oluwakemi Jumoke

AU - Analikwu, Claret Chinenyenwa

AU - Egbon, Eghosasere

AU - Fapohunda, Oluwaseun

AU - Boussios, Stergios

PY - 2025/12/1

Y1 - 2025/12/1

KW - Differentiation therapy

KW - Epigenetic regulation

KW - Tumor Microenvironment

KW - Cellular Reprogramming

KW - Cancer Reversion

U2 - https://www.mdpi.com/1467-3045/47/12/1049

DO - https://www.mdpi.com/1467-3045/47/12/1049

M3 - Article

SN - 1467-3037

VL - 47

SP - 1049

JO - Current Issues in Molecular Biology

JF - Current Issues in Molecular Biology

IS - 12

ER -